jrnl8047

Publication Venue For

  • Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery Versus Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial.  75:25-27. 2020
  • Effect of Vaginal Mesh Hysteropexy Versus Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial.  75:23-25. 2020
  • Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement.  74:703-704. 2019
  • The Efficacy and Safety of Tipapkinogen Sovacivec Therapeutic HPV Vaccine in Cervical Intraepithelial Neoplasia Grades 2 and 3: Randomized Controlled Phase II Trial with 2.5 Years of Follow-up.  74:529-530. 2019
  • A 12-month clinical durability of effectiveness and safety evaluation of a vaginal bowel control system for the nonsurgical treatment of fecal incontinence.  74:404-405. 2019
  • Evidence-based review of vaginal native tissue hysteropexy for uterovaginal prolapse.  74:429-435. 2019
  • Effect of immediate vs delayed pushing on rates of spontaneous vaginal delivery among nulliparous women receiving neuraxial analgesia: A randomized clinical trial.  74:131-133. 2019
  • Neonatal Outcomes of Elective Early-term Births After Demonstrated Fetal Lung Maturity.  74:66-67. 2019
  • Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.  73:689-690. 2018
  • Surgical outcomes after apical repair for vault compared with uterovaginal prolapse.  73:347-348. 2018
  • Association of Pharmacologic Treatment of Urgency Urinary Incontinence with Sleep Quality and Daytime Sleepiness.  73:273-274. 2018
  • Effect of Therapeutic Hypothermia Initiated after 6 Hours of Age on Death or Disability among Newborns with Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.  73:141-143. 2018
  • The FL/AC Ratio for Prediction of Shoulder Dystocia in Women with Gestational Diabetes.  73:129-130. 2018
  • Lessons Learned from Domestic and International Human Papillomavirus Vaccination Programs: A Review.  73:94-95. 2018
  • Contraception after Delivery among Publicly Insured Women in Texas: Use Compared with Preference.  73:5-6. 2018
  • Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.  73:22-24. 2018
  • Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.  72:709-711. 2017
  • Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement.  72:515-517. 2017
  • Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy.  72:464-465. 2017
  • Readmission and Prolapse Recurrence after Abdominal and Vaginal Apical Suspensions in Older Women.  72:161-163. 2017
  • Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.  72:11-13. 2017
  • Antenatal betamethasone for women at risk for late preterm delivery.  71:453-455. 2016
  • Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.  71:344-345. 2016
  • Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.  71:7-9. 2016
  • A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis.  70:735-737. 2015
  • Sexual Health in America: Improving Patient Care and Public Health.  70:752-754. 2015
  • Between-hospital variation in treatment and outcomes in extremely preterm infants.  70:549-551. 2015
  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease.  70:489-490. 2015
  • Effect of depth and duration of cooling on deaths in the NICU among Neonates with hypoxic ischemic encephalopathy: A randomized clinical trial.  70:235-238. 2015
  • A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in women.  70:446-448. 2015
  • A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: The ACT cluster randomized trial.  70:379-381. 2015
  • A vaginal bowel-control system for the treatment of fecal incontinence.  70:387-388. 2015
  • American society of clinical oncology position statement on obesity and cancer.  70:28-29. 2015
  • Tenofovir-based preexposure prophylaxis for HIV infection among African women.  70:444-446. 2015
  • Vitamin D deficiency is associated with increased fecal incontinence symptoms.  70:87-88. 2015
  • Why do pregnant women die? A review of maternal deaths from 1990 to 2010 at the University of Alabama at Birmingham: Editorial comment.  70:155-157. 2015
  • Bowel preparation before vaginal prolapse surgery: A randomized controlled trial.  69:252-253. 2014
  • Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials.  69:83-85. 2014
  • Prenatal whole-genome sequencing: Is the quest to know a fetus's future ethical?.  69:197-199. 2014
  • Urinary bacteria in adult women with urgency urinary incontinence.  69:327-328. 2014
  • What happens to the posterior compartment and bowel symptoms after sacrocolpopexy?: Evaluation of 5-year outcomes from E-CARE.  69:734-735. 2014
  • Activity restriction among women with a short cervix.  68:727-728. 2013
  • Implementing genomic medicine in the clinic: The future is here.  68:621-623. 2013
  • Urinary incontinence in the 12-month postpartum period.  68:629-630. 2013
  • Caffeine and urinary incontinence in US women: Editorial comment.  68:432-433. 2013
  • Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures: Editorial comment.  68:434-435. 2013
  • Measuring outcomes in urogynecological surgery: Perspective is everything.  68:355-357. 2013
  • The effect of the APPRISE mandate on use of erythropoiesis-stimulating agents and transfusion rates in patients with ovarian cancer receiving chemotherapy.  68:291-292. 2013
  • Anticholinergic therapy vs. OnabotulinumtoxinA for urgency urinary incontinence.  68:102-104. 2013
  • A midurethral sling to reduce incontinence after vaginal prolapse repair.  67:629-631. 2012
  • A randomized trial of urodynamic testing before stress-incontinence surgery.  67:628-629. 2012
  • Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.  67:215-217. 2012
  • Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: A randomized controlled trial.  66:427-429. 2011
  • Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.  66:285-287. 2011
  • DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE).  66:143-144. 2011
  • Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet.  65:769-770. 2010
  • Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection.  65:484-485. 2010
  • Outcome of term infants using apgar scores at 10 minutes following hypoxic-ischemic encephalopathy.  65:217-218. 2010
  • A multicenter, randomized trial of treatment for mild gestational diabetes.  65:69-70. 2010
  • Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length.  65:73-74. 2010
  • Effects of periodontal therapy on rate of preterm delivery: A randomized controlled trial.  65:6-7. 2010
  • Vaccine prevention of maternal cytomegalovirus infection.  64:502-504. 2009
  • Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trial.  64:521-523. 2009
  • Timing of elective repeat cesarean delivery at term and neonatal outcomes.  64:293-295. 2009
  • Weight loss to treat urinary incontinence in overweight and obese women.  64:317-318. 2009
  • Association between microdeletion and microduplication at 16p11.2 and autism.  63:361-363. 2008
  • Factors associated with 5-year risk of hip fracture in postmenopausal women.  63:234-235. 2008
  • Teriparatide or alendronate in glucocorticoid-induced osteoporosis.  63:232-233. 2008
  • Interconceptional antibiotics to prevent spontaneous preterm birth: A randomized clinical trial.  61:496-497. 2006
  • Low-Fat dietary pattern and risk of invasive breast cancer: The women's health initiative randomized controlled dietary modification trial.  61:454-456. 2006
  • Low-fat dietary pattern and risk of cardiovascular disease: The women's health initiative randomized controlled dietary modification trial.  61:451-453. 2006
  • Low-fat dietary pattern and risk of colorectal cancer: The women's health initiative randomized controlled dietary modification trial.  61:456-458. 2006
  • Calcium plus vitamin D supplementation and the risk of colorectal cancer: Commentary.  61:389-390. 2006
  • Calcium plus vitamin D supplementation and the risk of fractures: Commentary.  61:386-388. 2006
  • Subclinical hypothyroidism and pregnancy.  61:415-420. 2006
  • Effectiveness of treatment strategies of some women with pelvic inflammatory disease.  61:23-25. 2006
  • A cost-effectiveness analysis of screening strategies for cervical intraepithelial neoplasia.  60:96-97. 2005
  • Bacterial vaginosis and risk of pelvic inflammatory disease.  60:99-100. 2005
  • Vulvovaginal symptoms in women with bacterial vaginosis.  60:26-28. 2005
  • Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic review.  58:351-358. 2003
  • A guest editorial: stump the professor..  57:785-787. 2002
  • Necrotizing fasciitis after cesarean delivery.  89:409-412. 1997
  • Longitudinal changes in adiposity associated with pregnancy: The cardia study.  50:4-6. 1995
  • Open laparoscopy without special instruments or sutures: Comparison with a closed technique.  49:687-688. 1994
  • Physicians’ behavior and their interactions with drug companies: A controlled study of physicians who requested additions to a hospital drug formulary.  49:550-553. 1994
  • Vaginal delivery from the persistent occiput posterior position: Influence on maternal and neonatal morbidity.  49:530-532. 1994
  • Cross-sectional study examining the relationship between fetal urine production and the amniotic fluid index at 38–43 weeks of gestation.  48:728-729. 1993
  • The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.  47:544-546. 1992
  • Predictors of morbidity and mortality in neonates with herpes simplex virus infections.  46:451-453. 1991
  • Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome.  43:543-545. 1988
  • Treatment of condyloma acuminatum with three different interferons administered intralesionallv: a double blind placebo controlled trial.  43:701-702. 1988
  • Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study.  41:48-50. 1986
  • Early repair of an external sphincter ani muscle and rectal mucosal dehiscence.  41:696-697. 1986
  • Bromocriptine as primary therapy for prolactin secreting macroadenomas; results of a prospective multicenter study.  40:649-650. 1985
  • Cesarean section: Changing incidence and indications.  39:437-438. 1984
  • Microbiologic study of infertile women at the time of diagnostic laparoscopy: Association of ureaplasrna urealyticurn with a defined subpopulation.  39:110-111. 1984
  • Retinopathy in toxemia of pregnancy.  36:485-486. 1981
  • The natural history of herpes simplex virus infection of mother and newborn.  36:359-361. 1981
  • The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns.  35:735-736. 1980
  • A role of fetal prolactin in lung maturation.  33:516-517. 1978
  • Evaluation of tetracycline or penicillin and ampicillin for treatment of acute pelvic inflammatory disease.  32:754-756. 1977